Aaron Jacob Krasner, MD
About
Titles
Attending Psychiatrist, Silver Hill Hospital, New Canaan CT; Assistant Professor of Clinical Psychiatry, Yale School of Medicine
Positions outside Yale
Director, psychiatry, Krasner Adolescent Institute
Biography
About Dr. Krasner
Aaron Krasner studied English literature and Hispanic Studies at Northwestern University College of Arts and Sciences in Evanston, IL where he earned a BA with honors. Upon graduation he joined Teach for America as a bilingual educator in California and earned a multi subjects teaching credential while teaching. He left teaching for medicine and completed a post baccalaureate degree in pre-medical studies from Mills College prior to earning his MD at the Feinberg School of Medicine, Northwestern University in Chicago, IL.
Dr. Krasner completed his adult and child and adolescent training in psychiatry at the New York State Psychiatric Institute and Columbia University prior to his role as the Whitaker Scholar in Developmental Neuropsychiatry. After serving as an Instructor in Clinical Psychiatry in the Child and Adolescent Psychiatry Division at Columbia University, Dr. Krasner joined the faculty at the Yale School of Medicine. He was the director of the Adolescent Transitional Living Program at Silver Hill Hospital before leaving to establish the Krasner Adolescent Institute, a private, interdisciplinary assessment team focused on innovation in psychiatric assessment for treatment refractory teens and families.
Dr. Krasner is also the president of the American Society for Adolescent Psychiatry.
Appointments
Education & Training
- Whitaker Fellow in Developmental Neuropsychiatry
- Columbia University/New York State Psychiatric Institute (2013)
- Child and Adolescent Psychiatry Resident
- Columbia University/New York State Psychiatric Institute (2012)
- Resident, Adult Psychiatry
- Columbia University/New York State Psychiatric Institute (2010)
- Internal Medicine Intern
- Columbia University Medical Center (2008)
- MD
- Northwestern University The Feinberg School of Med (2007)
- Pre Medical Post Baccalaureate Certificate
- Mills College, Oakland CA (2002)
- Multiple Subjects Teaching Credential
- California State Hayward (2000)
- BA
- Northwestern University, English (1997)
Research
Publications
2016
Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis
Fung L, Mahajan R, Nozzolillo A, Bernal P, Krasner A, Jo B, Coury D, Whitaker A, Veenstra-Vanderweele J, Hardan A. Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis. Pediatrics 2016, 137: s124-s135. PMID: 26908468, DOI: 10.1542/peds.2015-2851k.Peer-Reviewed Original ResearchConceptsPharmacologic treatmentSide effectsPrimary study outcome measureAutism spectrum disorderPlacebo-controlled RCTsExtrapyramidal side effectsStudy outcome measuresEnd of treatmentRisk of biasParallel group designYouth ages 2Potential side effectsPublic health issueDetails of interventionsEffect sizeMedication groupAdverse reactionsSevere irritabilityOutcome measuresSignificant efficacyLarge effect sizesMeta-AnalysisSystematic reviewStudy participantsWeight gain
2015
ADHD Symptoms in a Non-Referred Low Birthweight/Preterm Cohort: Longitudinal Profiles, Outcomes, and Associated Features
Krasner AJ, Turner JB, Feldman JF, Silberman AE, Fisher PW, Workman CC, Posner JE, Greenhill LL, Lorenz JM, Shaffer D, Whitaker AH. ADHD Symptoms in a Non-Referred Low Birthweight/Preterm Cohort: Longitudinal Profiles, Outcomes, and Associated Features. Journal Of Attention Disorders 2015, 22: 827-838. PMID: 26700791, PMCID: PMC4919227, DOI: 10.1177/1087054715617532.Peer-Reviewed Original ResearchConceptsClinical featuresPreterm birth cohortHigh-risk cohortPreterm cohortFunctional outcomePositive screenPsychiatric disordersBirth cohortADHD evaluationSymptom trajectoriesMotor problemsHyperactive-impulsive symptomsCohortPoor functioningLatent class analysisAssociated featuresStudy objectivePossible ADHDSchool ageAutism spectrum disorderDisordersOutcomesSpectrum disorderADHDClass analysis
2013
Being with the patient: the use of "clinical evidence," reconsidered.
Harper G, Becker DF, Copans SA, Flaherty LT, Ghalib K, Krasner AJ, Kwok S, Onesti SJ, Wittenberg J. Being with the patient: the use of "clinical evidence," reconsidered. The Journal Of Nervous And Mental Disease 2013, 201: 813-7. PMID: 23995038, DOI: 10.1097/NMD.0b013e3182a2142f.Peer-Reviewed Original Research
2007
DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene.
Duan J, Martinez M, Sanders AR, Hou C, Burrell GJ, Krasner AJ, Schwartz DB, Gejman PV. DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene. Human Heredity 2007, 64: 97-106. PMID: 17476109, PMCID: PMC2861529, DOI: 10.1159/000101961.Peer-Reviewed Original Research
2005
Neuregulin 1 (NRG1 ) and schizophrenia: analysis of a US family sample and the evidence in the balance.
Duan J, Martinez M, Sanders AR, Hou C, Krasner AJ, Schwartz DB, Gejman PV. Neuregulin 1 (NRG1 ) and schizophrenia: analysis of a US family sample and the evidence in the balance. Psychological Medicine 2005, 35: 1599-610. PMID: 16219118, DOI: 10.1017/S0033291705005428.Peer-Reviewed Original Research